Summit Securities Group’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,000
Closed -$200K 1338
2026
Q1
$200K Buy
+5,000
New +$237K 0.02% 227
2023
Q3
Sell
-157,147
Closed -$7.48M 941
2023
Q2
$7.48M Buy
157,147
+148,660
+1,752% +$7.17M 0.98% 17
2023
Q1
$413K Buy
+8,487
New +$432K 0.03% 153
2022
Q4
Sell
-1
Closed 1326
2022
Q3
$0 Buy
+1
New +$49 ﹤0.01% 1122
2021
Q2
Sell
-7,073
Closed -$365K 828
2021
Q1
$365K Hold
7,073
0.04% 399
2020
Q4
$396K Buy
+7,073
New +$377K 0.03% 403
2020
Q3
Sell
-15,393
Closed -$798K 471
2020
Q2
$699K Buy
+15,393
New +$689K 0.09% 187

Other funds holding QGEN

Summit Securities Group's QGEN Position: Q2 2026 in Review

Summit Securities Group sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 5,000 shares — an estimated $200K sold.

Summit Securities Group first reported a position in QGEN in Q2 2020 and held it in 7 quarters. The position peaked at $7.48M in Q2 2023. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Summit Securities Group reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • Summit Securities Group sold 5,000 Qiagen shares in Q2 2026, an estimated $200K.
  • Summit Securities Group first reported a position in Qiagen in Q2 2020 and held it in 7 quarters.
  • Summit Securities Group's Qiagen position peaked at $7.48M in Q2 2023.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.